
    
      Eligible patients will receive vinflunine as a 15-20 minute intravenous (IV)infusion once
      every three weeks (21 days). This three week treatment period is called a cycle. Patients
      whose cancer has not grown or if it has decreased in size may receive up to 6 cycles of
      vinflunine. Evaluation will be conducted every other cycle.
    
  